160 related articles for article (PubMed ID: 33034812)
1. Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose.
Pinkawa M; Gharib A; Schlenter M; Timm L; Eble MJ
Qual Life Res; 2021 Feb; 30(2):437-443. PubMed ID: 33034812
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer.
Leufgens F; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):382-388. PubMed ID: 31201895
[TBL] [Abstract][Full Text] [Related]
3. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
[TBL] [Abstract][Full Text] [Related]
4. Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.
Pinkawa M; Fischedick K; Gagel B; Piroth MD; Asadpour B; Klotz J; Borchers H; Jakse G; Eble MJ
BMC Cancer; 2009 Aug; 9():296. PubMed ID: 19703300
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
[TBL] [Abstract][Full Text] [Related]
6. Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.
Pinkawa M; Piroth MD; Fischedick K; Nussen S; Klotz J; Holy R; Eble MJ
Radiat Oncol; 2009 Sep; 4():36. PubMed ID: 19772568
[TBL] [Abstract][Full Text] [Related]
7. Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.
Pinkawa M; Piroth MD; Fischedick K; Holy R; Klotz J; Nussen S; Krenkel B; Eble MJ
Strahlenther Onkol; 2009 Nov; 185(11):724-30. PubMed ID: 19899005
[TBL] [Abstract][Full Text] [Related]
8. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
[TBL] [Abstract][Full Text] [Related]
9. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.
Pinkawa M; Piroth MD; Holy R; Djukic V; Klotz J; Krenkel B; Eble MJ
Strahlenther Onkol; 2011 Aug; 187(8):479-84. PubMed ID: 21789739
[TBL] [Abstract][Full Text] [Related]
10. Erectile dysfunction after external beam radiotherapy for prostate cancer.
Pinkawa M; Gagel B; Piroth MD; Fischedick K; Asadpour B; Kehl M; Klotz J; Eble MJ
Eur Urol; 2009 Jan; 55(1):227-34. PubMed ID: 18375048
[TBL] [Abstract][Full Text] [Related]
11. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
[TBL] [Abstract][Full Text] [Related]
12. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire.
Nguyen LN; Pollack A; Zagars GK
Urology; 1998 Jun; 51(6):991-7. PubMed ID: 9609638
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.
Little DJ; Kuban DA; Levy LB; Zagars GK; Pollack A
Urology; 2003 Oct; 62(4):707-13. PubMed ID: 14550448
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
[TBL] [Abstract][Full Text] [Related]
15. Transurethral resection of the prostate after radiotherapy for prostate cancer: impact on quality of life.
Pinkawa M; Klotz J; Djukic V; Petz D; Holy R; Eble MJ
Int J Urol; 2014 Sep; 21(9):899-903. PubMed ID: 24724611
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
Schlenter M; Berneking V; Krenkel B; Mottaghy FM; Vögeli TA; Eble MJ; Pinkawa M
Strahlenther Onkol; 2018 Jul; 194(7):638-645. PubMed ID: 29511777
[TBL] [Abstract][Full Text] [Related]
18. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
Stone NN; Stock RG
Urology; 2007 Feb; 69(2):338-42. PubMed ID: 17320674
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis.
Pinkawa M; Piroth MD; Holy R; Escobar-Corral N; Caffaro M; Djukic V; Klotz J; Eble MJ
Strahlenther Onkol; 2012 Oct; 188(10):917-25. PubMed ID: 22933033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
